ATER News and Press, Aterian Inc. From 04/05/22

Sunshine Biopharma (SBFM) +119% newly designed mRNA molecules prove effective against multidrug resistant cancer cells. System1 (SST) +26%. Recon Technology (RCON) +23%. Aterian (ATER) +13%. Guardforce AI (GFAI) +12% on expanding applications of robotics solutions. Arcus Biosci...

Stock Market Futures Dip As Recession Concerns Rise Amidst Rising Ukraine-Russia Tensions U.S. stock futures are trading lower in early morning trading today. This comes after a relatively good session for the broader stock market. Now, a main focus for investors could be the on...

Aterian (NASDAQ:ATER) skyrocketed 53% on high volume in Monday trading despite no new press releases or SEC filings. A high level of short interest outstanding on Aterian has made the stock a short squeeze candidate.  Shares of Aterian (ATER) traded as high as $3.93 vs. the 52-week range...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the most explosive winners in today’s market is tech company Aterian (NASDAQ: ATER ), as retail investors focus in on a potential short squeeze. Currently, ATER stock has surged more than 60% on yet anot...

Gainers: Protalix BioTherapeutics (PLX) +74%. Aterian (ATER) +62%. Dingdong Limited (DDL) +40%. Jumia Technologies (JMIA) +30%. Twitter (TWTR) +27%. Takung Art (TKAT) +24%. Gracell Biotechnologies (GRCL) +22%. Cognition Therapeutics (CGTX) +21%. Poema Global Holdings (PPGH) +20%. Biophytis (B...

Protalix BioTherapeutics (PLX) +48% as PRX–102 for Fabry disease equals Sanofi's Fabrazyme in trial. SPI Energy (SPI) +28%. Twitter (TWTR) +20% Trump SPAC Digital World sinks on report two Truth Social executives left, Musk takes Twitter stake. Red Cat Holdings (OTC...

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) announced that effective today Cynthia Williams has joined the Company's Board of Directors (the “Board”). Williams is an experienced e-comm...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Contrarian investors looking for bargain-buying opportunities on fundamentally strong businesses should check out this list of stocks hit by supply chain issues. Some of the companies covered here could offer high stock inv...

Company reports fourth quarter results largely in line with expectations. Contribution margin continues to deteriorate. On the conference call, management issued disappointing Q1 guidance as the business continues to be impacted by rising inflation and supply chain disruptions. At...

Aterian, Inc. (ATER) Q4 2021 Earnings Conference Call March 8, 2022 5:00 PM ET Company Participants Ilya Grozovsky - Director, Investor Relations and Corporate Development Yaniv Sarig - Co-Founder and CEO Arturo Rodriguez - Chief Financial Officer Conference Call Participants Brian Nagel - Op...